Study Notes on Musculoskeletal Disorders and Management
Musculoskeletal Disorders and Management
General Overview
Presenters:
Dr. Anna George, PhD, APRN, NP-C
Dr. Kerry Mastrangelo, DNP, APRN, NP-C
Focus on various musculoskeletal conditions:
Osteoarthritis
Rheumatoid Arthritis
Gout
Osteomyelitis
Osteoporosis
Sprains/Strains/Fractures
Ligament/Tendon/Cartilage Injuries
Carpal/Cubital Tunnel Syndromes
Epicondylitis
Fibromyalgia
Back Pain
Osteoarthritis (OA)
Etiology
Involves mechanical and biological processes leading to degradation of articular cartilage in joints.
Most vulnerable joints: hips, knees, hands, and spine.
Progression: leads to a 'bone on bone' state.
Incidence
Affects 25% of adults; chronic condition primarily in those aged 65 and older.
Higher prevalence in women compared to men.
Risk Factors
Advancing age
Joint overuse and trauma
Obesity
Genetic predisposition and metabolic disorders (e.g., gout, hyperparathyroidism)
Prevention and Screening
Maintain physical activity and ideal body weight.
Avoid obesity; control metabolic and endocrine disorders.
Clinical Presentation
History
Gradual onset of joint pain, tenderness, and stiffness.
Symptoms worsen with activity and improve with rest.
Morning stiffness lasts less than 30 minutes.
Joint instability in later stages.
Physical Examination
Pain often localized to affected joints, most common in the hands.
Tenderness, stiffness, and coolness to touch are typical findings.
Signs: Bouchard's nodes (PIP joints) and Heberden's nodes (DIP joints).
Crepitus and mild joint effusion may be present.
Diagnosis and Differential Diagnosis
Imaging Studies
Use X-rays to identify uneven and narrowed joint spaces indicating destruction.
Laboratory Tests
No specific lab tests available; use normal RF (rheumatoid factor) testing and uric acid levels to rule out rheumatoid arthritis and gout respectively.
Differential Diagnoses
Consider conditions such as rheumatoid arthritis, psoriatic arthritis, gout, septic arthritis, Lyme disease, and lupus.
Dexa and QCT scans help assess bone mineral density.
Management of Osteoarthritis
Goals
Symptom relief, maintain/improve joint function, and avoid negative medication effects.
Non-Pharmacological Approaches
Encourage physical activity, supervised therapy, and self-management programs.
Utilize ambulation aids and surgical intervention when necessary.
Pharmacological Management
OTC options: acetaminophen (1 gm BID), NSAIDs (e.g., Naproxen), with caution for patients over 65 or those with GI issues.
Naproxen 500 mg BID, Diclofenac 50 mg, Motrin 600 mg TID, Meloxicam 15 mg QD.
Consider COX-2 inhibitors (e.g., Celebrex 200 mg daily) for lower GI toxicity.
Topical therapies: Voltaren gel, Capsaicin cream.
Short-term narcotics if necessary, intra-articular corticosteroid injections limited to 3 per year.
Joint replacement for severe, refractory cases.
Rheumatoid Arthritis (RA)
Pathophysiology
Chronic, systemic inflammatory disease affecting primarily synovial joints with symmetrical distribution.
Significant destruction of small joints and extra-articular symptoms prominent.
Incidence and Demographics
Worldwide incidence with juvenile RA occurring in children <16 years with chronic inflammation.
Affects >5 joints in adults; 3 times more common in women.
Risk Factors
Potential genetic components, autoimmune conditions, age (common between 30 and 50), and family history of autoimmune diseases.
Clinical Presentation
History
Critical to diagnose early for better prognosis.
Symptoms include malaise, fever, weight loss, morning stiffness longer than 30 minutes, and symmetrical joint involvement (75% knees, then elbows/ankles).
Physical Examination
Edema, erythema, warmth, tenderness, and subcutaneous nodules common.
Systemic manifestations can impact various body systems.
Diagnosis
Diagnostic Criteria
Use criteria based on the number of affected joints, serum RF factor status, duration of symptoms, CRP, and ESR levels.
Total score of 6 required for definitive diagnosis.
Differential Diagnoses
Consider SLE, psoriatic arthritis, septic arthritis, Lyme disease, gout, and osteoarthritis.
Management of RA
Goals
Early intervention to limit joint damage and improve mobility.
Non-Pharmacological Approaches
Important: complete rest during acute inflammation.
Physical and occupational therapies focus on strengthening and joint function.
Pharmacological Management
1st line: DMARDs. Start Methotrexate 7.5-10 mg weekly, titrate up depending on response.
NSAIDs can be used alongside DMARDs.
Biological agents (e.g., Etanercept and Infliximab) may cause hypersensitivity reactions and require careful monitoring.
Corticosteroids may be used for exacerbations and require tapering post-treatment.
Gout
Etiology
Metabolic disease leading to arthritis, caused by uric acid or monosodium urate crystal deposits.
Can be primary (genetic) or secondary (underlying conditions).
Clinical Presentation
History
Sudden pain, usually in the big toe, accompanied by fever, malaise.
Physical Examination
Acute attacks display affected joints as red, hot, swollen, and tender.
Diagnostic Studies
CBC, joint aspirate for needle-shaped crystals (gold standard), serum uric acid levels.
Differential Diagnoses
Include septic joints, pseudogout, RA, and cellulitis.
Management of Gout
Non-Pharmacological Approaches
Dietary modifications, hydration, rest during attacks.
Pharmacological Management
First-line: NSAIDs (Indomethacin, Naproxen).
Corticosteroids if NSAIDs are contraindicated.
Long-term maintenance: Allopurinol to maintain uric acid < 6 mg/dL; can use Probenecid as second-line treatment.
Osteomyelitis
Overview
Local bone infection, can be acute or chronic, typically bacterial (most commonly Staphylococcus aureus).
Clinical Presentation
History
Trauma history common in 75% of cases; fever with localized symptoms.
Physical Exam
Swelling, erythema, possible abscess formation.
Diagnostic Tests
CBC, elevate ESR & CRP, positive blood and bone cultures, MRI to define infection extent.
Management
Surgical debridement and prolonged IV antibiotic therapy are the mainstay treatment.
Osteoporosis
Definition
Metabolic disease characterized by decreased bone density and increased fracture risk.
Incidence & Risk Factors
Affects millions, particularly postmenopausal women and those at risk include genetic predisposition, vitamin D deficiency, and advanced age.
Management
Non-Pharmacological Treatment
Weight-bearing exercises, adequate calcium (1000-2500 mg/day) and vitamin D (400-800 IU) intake.
Pharmacological Options
First-line: Bisphosphonates (e.g., Alendronate) for inhibiting bone resorption.
SERMs and Calcitonin can be options depending on patient profile.
Sprains and Strains
Definition
Sprain: injury to ligaments; Strain: injury to muscles/tendons.
Incidence and Risk Factors
Common in sports; can occur in sedentary individuals as well.
Management
RICE (Rest, Ice, Compression, Elevation) for minor injuries; NSAIDs for pain.
Severe cases may require physical therapy or surgery.
Carpal Tunnel and Cubital Tunnel Syndromes
Etiology and Risk Factors
Overuse syndromes primarily due to repetitive wrist movements leading to median nerve or ulnar nerve compression, respectively.
Clinical Presentation
Symptoms may include burning pain, numbness, and weakness in the hand.
Management
Non-pharmacological: wrist splinting, ergonomic adjustments.
Pharmacological: NSAIDs, corticosteroid injections; surgery may be necessary if conservative management fails.
Epicondylitis (Tennis and Golfer's Elbow)
Etiology
Overuse injuries affecting the tendons of the forearm caused by repetitive motions.
Assessment & Management
Physical examination reveals tenderness over the epicondyles.
Management includes rest, ice, physiotherapy, and sometimes corticosteroidal injections.
Fibromyalgia
Definition
Characterized by widespread muscle pain and tenderness.
Management
Gradual exercise programs, cognitive-behavioral therapy, and medications like SSRIs and other pain management agents may be used.
Low Back Pain
Incidence and Risks
Common and often resolves with conservative management within weeks; complex differential diagnosis.
Management
Conservative treatment with NSAIDs and physiotherapy, education on proper body mechanics and appropriate activity levels are recommended.